Tag: CX

Artificial intelligence could make endovascular aortic repair outcomes more predictable, CX...

At the 2022 Charing Cross (CX) International Symposium (April 26–28) in London, England, Tom Carrell, MD, a vascular surgeon in Cambridge, England, and founder of...

New sirolimus data provide encouragement despite ‘potentially disappointing’ efficacy results

The results of a small-scale pilot study from Asia have indicated “potentially disappointing” results with a novel drug-eluting balloon in treating dysfunctional arteriovenous access...

CX 2022: IN.PACT AV DCB shows sustained and superior performance compared...

New randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug-coated balloons (DCBs) compared to percutaneous transluminal angioplasty (PTA) through 36...

CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant...

To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...

Nearly 70% of CX 2020 LIVE global aortic audience finds type...

A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering virtual...

CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era

CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, live, from 95 countries across...

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event

The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed...

Global vascular community addresses geographic disparity in COVID-19 impact and response

LONDON—Last week, the Charing Cross (CX) Symposium 2020 would have taken place in the U.K. capital. To mark the occasion virtually, experts from across...